Intest Res.  2018 Oct;16(4):507-508. 10.5217/ir.2018.00136.

Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases

Affiliations
  • 1Department of Gastroenterology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. bowelkim@gmail.com

Abstract

No abstract available.


MeSH Terms

Humans
Inflammatory Bowel Diseases*
Leukocyte L1 Antigen Complex*
Leukocyte L1 Antigen Complex

Reference

1. Lee KM. Fecal biomarkers in inflammatory bowel disease. Intest Res. 2013; 11:73–78.
Article
2. Wei SC. Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease? Intest Res. 2016; 14:293–294.
Article
3. Lewis JD. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology. 2011; 140:1817–1826. e2.
Article
4. Arai T, Takeuchi K, Miyamura M, et al. Level of fecal calprotectin correlates with severity of small bowel Crohn’s disease, measured by balloon-assisted enteroscopy and computed tomography enterography. Clin Gastroenterol Hepatol. 2017; 15:56–62.
Article
5. Kawashima K, Ishihara S, Yuki T, et al. Fecal calprotectin more accurately predicts endoscopic remission of Crohn’s disease than serological biomarkers evaluated using balloon-assisted enteroscopy. Inflamm Bowel Dis. 2017; 23:2027–2034.
Article
6. Lasson A, Stotzer PO, Öhman L, Isaksson S, Sapnara M, Strid H. The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis. J Crohns Colitis. 2015; 9:26–32.
Article
7. Moum B, Jahnsen J, Bernklev T. Fecal calprotectin variability in Crohn’s disease. Inflamm Bowel Dis. 2010; 16:1091–1092.
Article
8. Naismith GD, Smith LA, Barry SJ, et al. A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn’s disease. Aliment Pharmacol Ther. 2013; 37:613–621.
Article
9. Wei SC, Tung CC, Weng MT, Wong JM. Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring. Intest Res. 2018; 16:546–553.
Article
10. Vinding KK, Elsberg H, Thorkilgaard T, et al. Fecal calprotectin measured by patients at home using smartphones: a new clinical tool in monitoring patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016; 22:336–344.
Article
Full Text Links
  • IR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr